Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
RationaleAlcohol dependence is the third leading cause of preventable death in the USA. While single-agent pharmacotherapies have variable efficacy, medication combinations may produce additive effects by modulating multiple neural pathways.ObjectivesHere, we examined in animal models of ethanol consumption and relapse the combined effects of ondansetron (a serotonin-3 antagonist) and topiramate (a GABA/glutamate modulator), two medications with demonstrated efficacy for treating alcohol dependence, hypothesizing that their combination would produce a more efficacious response.MethodsThe effects of acutely administered ondansetron (0–0.01 mg/kg) and topiramate (0–10 mg/kg) alone and in combination on ethanol consumption were examined in alcohol preferring (P) rats (N = 20) and in rats from their background strain (Wistars, N = 20) using a 24-h access free-choice paradigm. Next, we examined their ability to prevent an increase in ethanol consumption following a deprivation period (i.e., an animal model of relapse).ResultsWhether administered alone or combined with ondansetron, topiramate produced a similar modest but persistent reduction in ethanol consumption. However, an analysis of efficacy by drinking level revealed that the combination was superior to topiramate alone in heavy-drinking P rats, but was without effect in lighter-drinking P rats and Wistar rats. Both topiramate alone and the combination blocked the alcohol deprivation effect in both Wistar and P rats with the combination tending to produce a greater decrease than topiramate alone.ConclusionsThe combination of ondansetron and topiramate may be a promising treatment for preventing relapse and for treating alcohol dependence in heavy-, but not lighter-drinkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Topiramate for Treating Alcohol Dependence<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
Johnson, B. A. (2007) · JAMA · doi:10.1001/jama.298.14.1641 · Cited by 542
Self-citationMedication treatment of different types of alcoholism
Johnson, B. A. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.08101500 · Cited by 151 · cited 1×
“Both ondansetron and topiramate are believed to modulate dopaminergic signaling (Johnson 2010), and when combined, it is possible that their effects on dopamine depend on basal levels.”
Self-citation
Cited by
Glutamatergic targets for new alcohol medications
Holmes, A., Spanagel, R., & Krystal, J. H. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3226-2 · Cited by 197
“In rodents, topiramate promotes alcohol intoxication and reduces alcohol drinking and withdrawal, but does not disrupt alcohol place preference (Breslin et al. 2010; Cagetti et al. 2004; Chen and Holmes 2009; Farook et al. 2007; Gremel et al. 2006; Hargreaves and McGregor 2007; Knapp et al. 2007; Lynch et al. 2011; Ng…”
BackgroundNeuroimmune signaling: a key component of alcohol abuse
Mayfield, J., Ferguson, L., & Harris, R. A. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.024 · Cited by 193
Moore, C. F., & Lynch, W. J. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.02.014 · Cited by 61
Self-citationOff-label and investigational drugs in the treatment of alcohol use disorder: A critical review
Fischler, P. V., Soyka, M., Seifritz, E., & Mutschler, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927703 · Cited by 34
“Preliminary studies in rodents, with a focus on a combination of ondansetron and topiramate, have also shown promising results, especially as regards heavy drinkers (Lynch et al., 2011; Moore et al., 2014).”
Background
Metadata
- Authors
- Lynch, W. J., Bond, C., Breslin, F. J., & Johnson, B. A.
- Venue
- Psychopharmacology
- Published
- 2011-03-22
- Volume
- 217
- Issue
- 1
- Pages
- 3-12
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2051204673
- Cited by
- 32
- References
- 2
- FWCI
- 2.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse. https://app.cochat.ai/papers/10.1007/s00213-011-2253-0
- The paper
- Lynch, W. J., Bond, C., Breslin, F. J., & Johnson, B. A. (2011). Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse. Psychopharmacology. https://doi.org/10.1007/s00213-011-2253-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.